Omalizumab improves angioedema-related quality of life impairment in chronic spontaneous urticaria patients: Results from the X-ACT study

被引：0
|
作者：
Weller, Karsten [1 ]
Staubach, Petra [2 ]
Metz, Martin [1 ]
Chapman-Rothe, Nadine [3 ]
Sieder, Christian [3 ]
Brautigam, Matthias [3 ]
Maurer, Marcus [1 ]
机构：
[1] Charite Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany
[2] Univ Med Ctr, Dept Dermatol, Utrecht, Netherlands
[3] Novartis Pharmaceut, Basel, Switzerland
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2018年 / 79卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
6835
引用
收藏
页码：AB209 / AB209
页数：1
相关论文
共 50 条
  • [21] Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patients
    Neisinger, Sophia
    Salameh, Pascale
    Gutsche, Annika
    Aulenbacher, Felix
    Siebenhaar, Frank
    Maurer, Marcus
    CLINICAL AND TRANSLATIONAL ALLERGY, 2025, 15 (01)
  • [22] SUSTAINED IMPROVEMENT IN WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN CHRONIC SPONTANEOUS URTICARIA (CSU) PATIENTS WITH OMALIZUMAB: RESULTS FROM XTEND-CIU
    Maurer, M.
    Rajput, Y.
    Thomas, C.
    Holden, M.
    Yoo, B.
    VALUE IN HEALTH, 2018, 21 : S243 - S243
  • [23] Barzolvolimab Improves Urticaria Control and Quality of Life in Patients with Chronic Spontaneous Urticaria: 52-Week Data
    Maurer, Marcus
    Metz, Martin
    Kobielusz-Gembala, Iwona
    Mitha, Essack
    Leflein, Jeffrey
    Gotua, Maia
    Fuentes-Duculan, Judilyn
    Paradise, Elsa
    Ma, Rick
    Green-berg, Steven
    Young, Diane
    Bernstein, Jonathan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02) : AB431 - AB431
  • [24] Quality of life, sleep, and psychological well-being in chronic spontaneous urticaria patients receiving omalizumab: a case–control study
    Mustafa Esen
    Abdullah Demirbaş
    Esin Diremsizoglu
    Archives of Dermatological Research, 317 (1)
  • [25] Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema
    Weller, Karsten
    Zuberbier, Torsten
    Maurer, Marcus
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 15 (03) : 220 - 226
  • [26] Omalizumab Therapy Response with gradual Dose Increase in Patients with chronic spontaneous Urticaria: Results of the OPTIMA Study
    Gulliver, Wayne
    Sussman, Gordon
    Hebert, Jaques
    Lynde, Charles
    Papp, Kim Alexander
    Yang, William H.
    Chambenoit, Olivier
    Vieira, Antonio
    deTakacsy, Frederica
    Rihakova, Lenka
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 11 - 11
  • [27] Disease Activity Only Moderately Correlates with Quality of Life Impairment in Patients with Chronic Spontaneous Urticaria
    Koti, I.
    Weller, K.
    Makris, M.
    Tiligada, E.
    Psaltopoulou, T.
    Papageorgiou, C.
    Baiardini, I.
    Panagiotakos, D.
    Braido, F.
    Maurer, M.
    DERMATOLOGY, 2013, 226 (04) : 371 - 379
  • [28] Omalizumab for chronic spontaneous urticaria in "complex" patients: data from real-life clinical practice
    Vollono, Laura
    Piccolo, Arianna
    Lanna, Caterina
    Esposito, Maria
    Bavetta, Mauro
    Campione, Elena
    Bianchi, Luca
    Diluvio, Laura
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 3181 - 3186
  • [29] Real-life study of patients treated with omalizumab in chronic spontaneous urticaria in France: One-year final results of LUCIOL study
    Barbaud, A.
    Staumont-Salle, D.
    Bouillet, L.
    Vicaut, E.
    Tetart, F.
    Azib-Meftah, S.
    Milpied, B.
    Fougerousse, A.
    Benjamin, K.
    Cartiaux, H.
    Lamirand, A.
    Bruno, N.
    Berard, F.
    ALLERGY, 2020, 75 : 319 - 320
  • [30] Omalizumab treatment in patients with severe chronic spontaneous urticaria: consideration from real-life experience in Italy
    Asero, Riccardo
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 : 1 - 2
12345